Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ocular microangiopathy in humans]

D Chauvaud1

  • 1INSERM U86, Service d'Ophtalmologie, Hôtel-Dieu, Paris, France.

Therapie
|March 21, 1998
PubMed
Summary
This summary is machine-generated.

Diabetic retinopathy, a microangiopathy, results from high blood sugar damaging retinal cells and blood vessels. Early treatment focuses on blood sugar control, while advanced stages may require laser therapy or surgery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Relevance of traditional hospitalizations in an ophthalmology department].

Journal francais d'ophtalmologie·2008
Same author

[Inadvertent intravitreal lidocaine injection following subcutaneous palpebral anesthesia: retinal toxicity of lidocaine?].

Journal francais d'ophtalmologie·2006
Same author

[Results of treating rhegmatogenous retinal detachment with vitrectomy and silicone oil tamponade].

Journal francais d'ophtalmologie·2006
Same author

[Multilocular eyelid hidrocystoma: an anatomical and clinical observation].

Journal francais d'ophtalmologie·2003
Same author

[Episcleral Miragel buckling elements removal. A clinical case-series].

Journal francais d'ophtalmologie·2003
Same author

[The place of surgery in subfoveal neovascular treatment in age-related macular degeneration].

Journal francais d'ophtalmologie·2002
Same journal

Pharmacology of pruritus (pathophysiology, therapeutic targets).

Therapie·2026
Same journal

Barriers to prescribing methylphenidate for adults with ADHD: A qualitative study.

Therapie·2026
Same journal

[Self-medication and its factors amongst Navymen aboard surface ships of the French Navy at sea: A descriptive study].

Therapie·2026
Same journal

Subacute cutaneous lupus erythematosus induced by ticagrelor: Recurrence after rechallenge.

Therapie·2026
Same journal

Multiple HIV virological failures related to bictegravir-valproic acid interaction evidenced by therapeutic drug monitoring: A retrospective study.

Therapie·2026
Same journal

Indication-related misuse of oral fluoroquinolones in adults by general practitioners in France.

Therapie·2026
See all related articles

Area of Science:

  • Ophthalmology
  • Diabetology
  • Vascular Biology

Context:

  • Diabetic retinopathy is a serious complication of diabetes mellitus.
  • Microangiopathy affects retinal endothelial cells and neural tissue.
  • Hyperglycemia triggers detrimental biochemical and structural changes in the retina.

Purpose:

  • To elucidate the mechanisms of diabetic microangiopathy.
  • To outline the functional and structural alterations in the retina due to hyperglycemia.
  • To review current and investigational treatments for diabetic retinopathy.

Summary:

  • Diabetic retinopathy involves impairments of the choriocapillaris, pigmented epithelium, neural layers, pericytes, and vitreoretinal interface.
  • Hyperglycemia leads to sorbitol accumulation, reduced myoinositol, decreased ATPase activity, and advanced glycation end products (AGEs).

Related Experiment Videos

  • Functional changes include impaired blood flow autoregulation and blood-retinal barrier breakdown; structural changes involve basement membrane thickening, pericyte loss, and cell proliferation.

    • Impact:

    • Capillary closure, driven by vascular endothelial growth factor (VEGF), initiates proliferative retinopathy.
    • Glycemic control is crucial for managing early-stage retinopathy.
    • Advanced stages benefit from laser photocoagulation and vitreo-retinal surgery; inhibitors are under investigation.